BDBM299642 US9593110, Example 101b::US9593110, Example 101c::US9593110, Example 102b::US9593110, Example 102c::US9593110, Example 103b::US9593110, Example 103d::US9593110, Example 105::US9593110, Example 106::US9593110, Example 87b::US9593110, Example 88b::US9593110, Example 89b::US9593110, Example 90b::US9593110, Example 91b::US9593110, Example 92b::US9593110, Example 93b::US9593110, Example 94b::US9593110, Example 95b

SMILES O=C(O)[C@H](CNCCCO)C[C@@H](Cc2ccc(C1=C(F)C=CC(Cl)C1)cc2)NC(=O)C3CN=NN3

InChI Key InChIKey=XUESFXPWPSYPQC-UHFFFAOYSA-N

Data  17 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 299642   

TargetNeprilysin(Human)
Theravence Biopharma R&D Ip

US Patent
LigandChemical structure of BindingDB Monomer ID 299642BDBM299642(US9593110, Example 87b)
Affinity DataKi: <1nMAssay Description:Recombinant human NEP and recombinant human ACE were obtained commercially (R&D Systems, Minneapolis, Minn., catalog numbers 1182-ZN and 929-ZN, resp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2019
Entry Details
US Patent